Bifogade filer
Repurchase of C-RAD B-shares week 32 - 2024
Kurs
+1,03%
Likviditet
1,62 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2026-02-10 | 08:30 | Bokslutskommuniké 2025 |
| 2025-10-23 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-07-18 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-08 | N/A | Årsstämma |
| 2025-05-07 | 08:30 | Kvartalsrapport 2025-Q1 |
| 2025-02-07 | 08:30 | Bokslutskommuniké 2024 |
| 2024-10-23 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-18 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-16 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2024-05-15 | - | Årsstämma |
| 2024-05-14 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-08 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-20 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2023-05-05 | - | Årsstämma |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-01-26 | - | Bokslutskommuniké 2022 |
| 2022-10-28 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-21 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-09 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2022-05-06 | - | Årsstämma |
| 2022-05-06 | - | Kvartalsrapport 2022-Q1 |
| 2022-01-27 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-29 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-10 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2021-05-07 | - | Årsstämma |
| 2021-05-07 | - | Kvartalsrapport 2021-Q1 |
| 2021-01-28 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-31 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-11 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2020-05-08 | - | Årsstämma |
| 2020-05-06 | - | Kvartalsrapport 2020-Q1 |
| 2020-01-31 | - | Bokslutskommuniké 2019 |
| 2019-12-17 | - | Extra Bolagsstämma 2019 |
| 2019-10-25 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-30 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-09 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2019-05-08 | - | Årsstämma |
| 2019-05-08 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-08 | - | Bokslutskommuniké 2018 |
| 2018-10-26 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-17 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-31 | - | Årsstämma |
| 2018-05-18 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-01-31 | - | Bokslutskommuniké 2017 |
| 2017-10-27 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-02 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2017-04-28 | - | Årsstämma |
| 2017-04-28 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-13 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Extra Bolagsstämma 2016 |
| 2016-11-14 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-24 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-09 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-15 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2016-04-14 | - | Årsstämma |
| 2016-02-08 | - | Bokslutskommuniké 2015 |
| 2015-11-06 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-14 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-08 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-17 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2015-04-16 | - | Årsstämma |
| 2015-01-30 | - | Bokslutskommuniké 2014 |
| 2014-11-07 | - | Kvartalsrapport 2014-Q3 |
| 2014-11-07 | - | Analytiker möte 2014 |
| 2014-08-15 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-16 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-17 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2014-04-16 | - | Årsstämma |
| 2014-02-17 | - | Bokslutskommuniké 2013 |
| 2013-11-28 | - | Kvartalsrapport 2013-Q3 |
| 2013-11-01 | - | Analytiker möte 2013 |
| 2013-10-30 | - | Extra Bolagsstämma 2013 |
| 2013-09-02 | - | 15-7 2013 |
| 2013-08-30 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-03 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2013-05-31 | - | Årsstämma |
| 2013-05-29 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-26 | - | Bokslutskommuniké 2012 |
| 2012-12-04 | - | Extra Bolagsstämma 2012 |
| 2012-11-28 | - | Kvartalsrapport 2012-Q3 |
| 2012-09-04 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-04 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2012-06-01 | - | Årsstämma |
| 2012-05-24 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-24 | - | Bokslutskommuniké 2011 |
| 2011-11-25 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-26 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-26 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2011-05-25 | - | Årsstämma |
| 2011-05-24 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-11 | - | Bokslutskommuniké 2010 |
| 2010-06-02 | - | X-dag ordinarie utdelning CRAD B 0.00 SEK |
| 2010-06-01 | - | Årsstämma |
| 2010-05-28 | - | Kvartalsrapport 2010-Q1 |
| 2009-11-27 | - | Kvartalsrapport 2009-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Between 5 and 9 of August 2024, C-RAD AB (publ) (LEI code 549300SPXLHF15W2CU25) has repurchased 70,000 own B-shares (ISIN: SE0002016352).
The repurchase is carried out in accordance with the Annual General Meeting's authorization to the Board to acquire shares in the Company. The purpose of the repurchase is to cover the Company’s obligations under previously resolved incentive programs.
| Date | Aggregated daily volume (number of shares): | Weighted average share price per day (SEK): | Total daily transaction value (SEK): |
| 2024-08-05 | 4,500 | 41.2246 | 185,511 |
| 2024-08-06 | 7,000 | 41.6192 | 291,334 |
| 2024-08-07 | 7,000 | 42.7328 | 299,130 |
| 2024-08-08 | 45,069 | 43.1954 | 1,946,773 |
| 2024-08-09 | 6,431 | 43.3383 | 278,709 |
| Total: | 70,000 | 42.8780 | 3,001,457 |
All acquisitions have been carried out on Nasdaq Stockholm by Pareto on behalf of C-RAD. Following the above acquisitions, C-RAD AB holds a total of 158,500 class B-shares in treasury as per 9 August 2024, equivalent to 0.47 percent of the total number of shares outstanding, and 0.38 percent of the votes.
The total number of shares outstanding in C-RAD AB, including shares held in treasury, is 33,766,935, where of 862,887 are Class A-shares and 32,904,048 are Class B-shares.
For further information:
Cecilia de Leeuw, CEO, +46 (0)795 85 66 77, investors@c-rad.com
Jonas Reinhammar, Interim CFO, +46 (0)762 406 402, investors@c-rad.com
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
C-RAD. Inspiring excellence in cancer treatment.
C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com